Shikonin exerts an anti-leukemia effect against FLT3-ITD mutated acute myeloid leukemia cells via targeting FLT3 tyrosine kinase and its downstream pathways

CONCLUSION: The findings of this study indicate that SHK is a promising drug for the treatment of FLT3-ITD mutated AML.PMID:37926079 | DOI:10.1159/000534101

Source: Acta Haematologica - November 5, 2023 Category: Hematology Authors: Mu-Nan Zhao Long Su Fei Song Zhi-Feng Wei Tian-Xue Qin Yun-Wei Zhang Wei Li Su-Jun Gao Source Type: research